Anesthesiology Doctors in Norwich, CT Accepting Medicare

9 Anesthesiology doctors found. Showing 1 - 9

Dr. Jeremy Gordon Burke, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, Department Of Anesthesiology, Norwich, CT 06360 Phone: 860-889-8331

Adam Drew Goldstein, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331

Daniel Hseuh, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331

Dr. William L Thompson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331

Dr. Alicia J Schade, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331

Dr. John Paggioli, M.D. Anesthesiology - Pain Medicine Medicare: Medicare Enrolled Practice Location: 190 W Town St, Norwich, CT 06360 Phone: 860-885-0333    Fax: 860-885-1319

Dr. Robert Lewis Ringering, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331

Dr. Cynthia Lynn Campbell, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 326 Washington Street, Norwich, CT 06360 Phone: 860-889-8331

Dr. Yong Nam Jo, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 325 Washington St, Anesthesia Dept, Norwich, CT 06360 Phone: 860-823-6395    Fax: 860-823-6563

News Archive

Fish consumption advisories for pregnant women ineffective in reducing infant exposure to POPs

A new modeling study suggests that fish consumption advisories for expecting mothers are ineffective in reducing infant exposure to long-lived contaminants like persistent organic pollutants (POPs).

Central sclera thickening characterises dome-shaped macula

A dome-shaped macula appears to result from the relative thickening of the central macular sclera, researchers have found.

Drug that unleashes immune system can produce lasting remissions in patients with melanoma

A drug that unleashes the immune system to attack cancer can produce lasting remissions and hold the disease in check - for more than two years, in some cases - in many patients with advanced melanoma, according to a new study by researchers at Dana-Farber Cancer Institute, Johns Hopkins University, Yale University, and allied institutions.

NW Bio receives decision to continue Phase III clinical trial on brain cancer in Germany

Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.

Read more Medical News

› Verified 4 days ago